TABLE 1.
Parameter | Value | Source |
Age at baseline years | 63.90±6.39 | FULFIL [4] |
Height m | 1.69±0.08 | FULFIL [4] |
Sex | ||
Male | 75.8 | TORCH [10] |
Age category years | ||
<55 | 11.5 | TORCH [10] |
55 to <65 | 32.3 | TORCH [10] |
65 to <75 | 43.7 | TORCH [10] |
≥75 | 12.6 | TORCH [10] |
Exacerbation history (moderate or severe, in the previous 12 months) | ||
0 | 43.0 | TORCH [10] |
1 | 24.8 | TORCH [10] |
≥2 | 32.3 | TORCH [10] |
BMI kg·m−2 | ||
<20 | 13.5 | TORCH [10] |
20 to <25 | 37.6 | TORCH [10] |
25 to <29 | 26.9 | TORCH [10] |
≥29 | 22.0 | TORCH [10] |
SGRQ total score | ||
<38 | 28.8 | TORCH [10] |
38 to <50 | 25.7 | TORCH [10] |
50 to <62 | 22.9 | TORCH [10] |
≥62 | 22.6 | TORCH [10] |
FEV1 % pred, baseline# | ||
<30% | 12.9 | FULFIL [4] |
30 to <50% | 54.5 | FULFIL [4] |
50 to <80% | 32.6 | FULFIL [4] |
≥80% | <1.0 | FULFIL [4] |
Data are presented as mean±sd or %. #: forced expiratory volume in 1 s (FEV1) % pred at baseline was not included in the model and is provided only as information describing lung function status at study entry. BMI: body mass index; SGRQ: St. George's Respiratory Questionnaire; TORCH: Towards a Revolution in COPD Health; FULFIL: Lung Function and Quality of Life Assessment in Chronic Obstructive Pulmonary Disease with Closed Triple Therapy.